Results 151 to 160 of about 3,164,975 (245)
ABSTRACT Adult‐onset Still's disease (AOSD) is a rare systemic autoinflammatory condition that presents with symptoms such as episodic fevers, a transient rash, inflammatory arthritis, and significant systemic inflammation. Diseases that have a relapsing–remitting clinical course can be challenging to diagnose and treat. We present a case of an 18 year
Tasnim Nafian +4 more
wiley +1 more source
ABSTRACT Systemic lupus erythematosus (SLE) can closely mimic rheumatoid arthritis, leading to diagnostic delays. In patients with atypical inflammatory arthritis, early echocardiographic evaluation is vital to detect rare but life‐threatening complications like cardiac tamponade, ensuring prompt transition from RA‐directed therapy to life‐saving ...
Ayush Bakhrel +5 more
wiley +1 more source
ABSTRACT Background Needlestick injuries (NSIs) remain a major occupational hazard among healthcare workers (HCWs), increasing the risk of exposure to blood‐borne infections such as hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus (HIV).
Abdullahi Hassan Elmi +3 more
wiley +1 more source
ABSTRACT Recurrence of focal segmental glomerulosclerosis (FSGS) following kidney transplantation remains a significant cause of allograft loss. Much remains unknown about the efficacy of apheresis treatments and the factors that determine favorable treatment outcomes.
Chimezie Godswill Okwuonu +4 more
wiley +1 more source
In nonspecialist departments, most anti‐HCV–positive individuals do not proceed to RNA testing. The Elecsys HCV Duo assay simultaneously detects anti‐HCV antibodies and core antigen from a single blood draw and preferentially identifies patients with clinically meaningful viral loads.
Hiroko Setoyama +23 more
wiley +1 more source
Soluble B7‐H6 as a Novel Diagnostic Biomarker for Post‐Hepatitis B Cirrhosis: A Clinical Value Study
This study investigates the potential of soluble B7‐H6 (sB7‐H6) as a novel diagnostic biomarker for post‐hepatitis B cirrhosis. The infographic visually presents the following key points: (1) Liver Disease Progression: Chronic hepatitis B (CHB) progresses to liver cirrhosis (LC), with serum sB7‐H6 levels increasing stepwise as the disease advances. (2)
Kaiyong Chen +4 more
wiley +1 more source
Bioimpedance Analysis to Predict Clinical Outcomes of Liver Cirrhosis in a Prospective Cohort Study
ABSTRACT Background and Aims Bioimpedance analysis (BIA) is a non‐invasive method for estimating body composition, which plays a role in the development of cirrhosis. We investigated if BIA measures were associated with cirrhosis complications. Methods We analyzed data from 566 participants in a prospective cohort study of cirrhosis patients from ...
Mohammed Kanan +9 more
wiley +1 more source
HCV‐Specific T‐Cell Recovery After a Year of SVR Following DAA Therapy
ABSTRACT Direct‐acting antiviral (DAA) drugs lead to sustained virologic response (SVR) in almost all treated patients with chronic hepatitis C virus (HCV) infection. Despite this success, the long‐term effects of HCV clearance by DAA therapy on T‐cell‐mediated antiviral immunity remain unclear, particularly concerning the restoration of immune ...
Tetiana Pozniak +9 more
wiley +1 more source
The seroprevalences of HBs Ag and anti-HCV in pregnant women in Ankara
S. Altınbaş +2 more
semanticscholar +1 more source
ABSTRACT COVID‐19 severity and survival are influenced by the host immune response to SARS‐CoV‐2. Programmed cell death 1 (PD‐1), a key immune checkpoint, regulates T‐cell activation and antiviral immune balance. Since genetic variability can modulate these responses, we investigated whether the PDCD1 polymorphisms rs11568821 C > T, rs2227982 G > A ...
Sarah Lott Moretto +6 more
wiley +1 more source

